Testing to aid in diagnosis
T-cell malignancies account for approximately 12% of all non-Hodgkin's lymphomas. With more than 30 identified subtypes of T-cell neoplasms, diagnosis can be difficult. Mayo Clinic Laboratories offers comprehensive fluorescence in situ hybridization (FISH) panels, as well as extensive immunohistochemistry (IHC) offerings, to diagnose and monitor T-cell lymphoma. In addition, Mayo Clinic’s hematopathology team has extensive experience with T-cell neoplasms and frequently provides consultations for clients around the globe.
The following FISH probes available at Mayo Clinic Laboratories are associated with specific T-cell lymphoma subtypes, including:
Comprehensive testing, simplified
Our approach to fluorescence in situ hybridization (FISH)testing is designed to simplify the ordering process by providing diagnostic panels that include all appropriate genes.
TLPMF | T-Cell Lymphoma, Specified FISH
PATHC | Pathology Consultation
Test in Focus
Andrew Feldman, M.D., discusses the importance of comprehensive testing to identify specific subtypes of T-cell lymphoma, which is not a single disease, rather a name given to a wide variety of disease with different pathologic and clinical features.